Breast Cancer

Right Breast Carcinoma

Female, 50 years

Patient Internal ID: 822117688

ICD-10 code

C50.9 Malignant Neoplasm Breast, Unspecified

Diagnosis (Incl. Metastases/Stage) and Year

May 2020
Right Breast Carcinoma ypT0ypN0sn(0/1) LV0, ER(-), PR(-), HER(-), Ki67 – 70-80%.

Previous Treatment

Chemotherapy (Carboplatin/Paclitaxel), Surgery, Radiation Therapy

Prognosis and Survival Expectation

The five-year relative survival rate for patients with Localized Triple-Negative Breast Cancer is 91%.

Treatment Provided

Autologous DCV over a period of 12 months. Additionally, the patient received Immunostimulation of Interferon (IFN) β and Tumor Ne crosis Factor (TNF).

Patient Survival/Condition and Year
Date of Review: 01/01/2024

The patient has survived for 3,5 years since the diagnosis with no signs of disease. The patient is attending regular follow-ups. It can be concluded that the addition of Immunotherapy, alongside Chemotherapy, Surgery and Radiation Therapy ,has benefited patient with disease stabilisation.

Disclaimer

We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.

Ok